DI 23022.202:
Joubert Syndrome
Effective Dates: 04/12/2017 - Present- Effective Dates: 03/28/2018 - Present
TN 10 (01-14)- TN 16 (03-18)
- DI 23022.202 Joubert Syndrome
- COMPASSIONATE ALLOWANCE INFORMATION
- JOUBERT SYNDROME
- ALTERNATE NAMES
- Agenesis of Cerebellar Vermis; Cerebello-Oculo-Renal Syndrome; Cerebellooculorenal Syndrome 1; Cerebelloparenchymal Disorder 4; Joubert-Bolthauser Syndrome; Joubert Syndrome and Related Disorders; Joubert Syndrome Type A; Pure Joubert Syndrome; Classic Joubert Syndrome
- DESCRIPTION
- Joubert Syndrome (JS) is a rare genetic disorder characterized by cerebellar and brain stem malformation resulting in a “molar tooth” sign seen on brain imaging studies such as magnetic resonance imaging (MRI), increased rigidity and spasticity of muscles (hypertonia), and developmental delay. Brain stem malformation may lead to abnormal eye and tongue movements in addition to respiratory problems. JS may be seen in isolation or may be related to several other disorders including retinal dystrophy, renal disease, ocular colobomas (missing pieces of tissues in or around the eye), occipital encephalocele, hepatic fibrosis, polydactyl (extra fingers and toes), oral hamartomas (nodules of mature cells and tissues), seizures, and other abnormalities. Infants with JS may have abnormally rapid breathing (hyperpnea), decreased muscle tone (hypotonia), jerky eye movements (oculomotor apraxia), intellectual impairment, and the inability to coordinate voluntary muscle movements (ataxia). JS appears to be inherited in an autosomal recessive manner (meaning both parents must have a copy of the mutation) via mutation in a number of genes, including NPHP1, AHI1, and CEP290. JS typically has an autosomal X-linked recessive pattern of inheritance.
- DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND ICD-9-CM CODING
- Diagnostic testing: The diagnosis for JS is established by a combination of clinical examination and imaging studies of the midbrain and pons that resemble the characteristic molar tooth sign. Genetic testing for mutations are identified in about 50% of the people with JS, including the NPHP1, CEP290, AHI1, TMEM67 (MKS3), RPGRIP1L, CC2D2A, ARL13B, INPP5E, OFD1, TMEM216, KIF7, TCTN1, TCTN2, TMEM237, CEP41, TMEM138, C5orf42, TMEM231, and TCTN3 genes.
- Physical findings: Hypotonia in infancy with later development of ataxia and developmental delays. Additional features in children with JS may include a large head, prominent forehead, high rounded eyebrows, epicanthal folds, ptosis, upturned nose with prominent nostrils, open mouth, tongue protrusion, rhythmic tongue motions, low-set and tilted ears.
- ICD-9: 759.89
- ONSET AND PROGRESSION
- Prognosis for children with Joubert Syndrome depends on the severity of the condition. The prognosis for infants with JS depends on whether or not the cerebellar vermis is partially developed or entirely absent. In some cases, the cerebellar vermis is almost fully developed, resulting in mild symptoms. The mildest form of the disease often results in mild lapses in motor control and mild intellectual disability. These individuals can live full, productive lives with medical and familial support.
- TREATMENT
- There is no definitive treatment available for JS. Treatment is supportive and symptom specific. Infants and children with abnormal breathing may require stimulatory medications; supplemental oxygen; mechanical support; or tracheostomy in rare cases. Other interventions may include speech therapy; occupational and physical therapy; educational support including special programs for the visually impaired; and feedings by gastrostomy tube. Surgery may be required for polydactyl and symptomatic ptosis or strabismus. End-stage renal disease, liver failure or fibrosis is treated with standard medical approaches. Children may require annual evaluations of growth, vision, and liver and kidney function and, periodic neuropsychological and developmental testing.
- SUGGESTED PROGRAMMATIC ASSESSMENT*
- Suggested MER for evaluation:
- * Clinical history and examination that describes the diagnostic features of the impairment and laboratory findings are needed to confirm the diagnosis.
- * Developmental assessment or psychological testing to address allegations of mental impairment may be warranted.
- Suggested Listings for Evaluation:
- DETERMINATION
- LISTING
REMARKS- Meets Listing
- 111.07
- 111.17
- 112.05
Listing-level neurological and/or cognitive findings must be documented; diagnosis on laboratory or genetic testing results alone does not meet listing severity.- Equals Listing
- 112.02
Must satisfy listing-level severity.- * Adjudicators may, at their discretion, use the Medical Evidence of Record or Listings suggested to evaluate the claim. However, the decision to allow or deny the claim rests with the adjudicator.
x
← This means that the line
was removed and
was added – in other words, the "Effective Dates" line at the top of the document has been updated to reflect that the new version is effective as of the date the change was made.